Status:
COMPLETED
Intravitreal Bevacizumab in Agioid Streaks
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
Angioid Streaks
Choroidal Neovascularization
Eligibility:
All Genders
44-67 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to investigate the safety and efficacy of intravitreal bevacizumab in patients with choroidal neovascularization associated with angioid streaks.
Detailed Description
To investigate the safety and efficacy of intravitreal bevacizumab in a patient with choroidal neovascularization associated with angioid streaks. One of the most serious ocular complication of angioi...
Eligibility Criteria
Inclusion
- presence of an active CNV
- visual loss
- increased retinal thickness
Exclusion
- no actively leaking CNV by FAG
- normal retinal thickness
- satisfactory visual acuity
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00406250
Start Date
November 1 2006
End Date
May 1 2009
Last Update
February 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dipartimento di Oftalmologia, SUN
Napoli, Napoli, Italy, 80100